These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21180650)

  • 1. Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?
    Frelin L; Brass A; Ahlén G; Brenndörfer ED; Chen M; Sällberg M
    Drug News Perspect; 2010 Dec; 23(10):647-53. PubMed ID: 21180650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant.
    Zhang L; Widera G; Rabussay D
    Bioelectrochemistry; 2004 Jun; 63(1-2):369-73. PubMed ID: 15110305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation.
    Dolter KE; Evans CF; Ellefsen B; Song J; Boente-Carrera M; Vittorino R; Rosenberg TJ; Hannaman D; Vasan S
    Vaccine; 2011 Jan; 29(4):795-803. PubMed ID: 21094270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroporation for DNA immunization: clinical application.
    van Drunen Littel-van den Hurk S; Hannaman D
    Expert Rev Vaccines; 2010 May; 9(5):503-17. PubMed ID: 20450325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroporation-enhanced delivery of nucleic acid vaccines.
    Broderick KE; Humeau LM
    Expert Rev Vaccines; 2015 Feb; 14(2):195-204. PubMed ID: 25487734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models.
    Draghia-Akli R; Khan AS; Brown PA; Pope MA; Wu L; Hirao L; Weiner DB
    Vaccine; 2008 Sep; 26(40):5230-7. PubMed ID: 18450333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin targeted DNA vaccine delivery using electroporation in rabbits. I: efficacy.
    Medi BM; Hoselton S; Marepalli RB; Singh J
    Int J Pharm; 2005 Apr; 294(1-2):53-63. PubMed ID: 15814230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle.
    van Drunen Littel-van den Hurk S; Luxembourg A; Ellefsen B; Wilson D; Ubach A; Hannaman D; van den Hurk JV
    Vaccine; 2008 Oct; 26(43):5503-9. PubMed ID: 18708108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep.
    Babiuk S; Tsang C; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel PJ
    Bioelectrochemistry; 2007 May; 70(2):269-74. PubMed ID: 17118714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
    Roos AK; Moreno S; Leder C; Pavlenko M; King A; Pisa P
    Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A; Hannaman D; Nolan E; Ellefsen B; Nakamura G; Chau L; Tellez O; Little S; Bernard R
    Vaccine; 2008 Sep; 26(40):5216-22. PubMed ID: 18462850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal delivery of protein and DNA vaccines.
    Dean HJ
    Expert Opin Drug Deliv; 2005 Mar; 2(2):227-36. PubMed ID: 16296750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.
    Yamaoka A; Guan X; Takemoto S; Nishikawa M; Takakura Y
    J Control Release; 2010 Mar; 142(3):411-5. PubMed ID: 19913062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin targeted DNA vaccine delivery using electroporation in rabbits II. Safety.
    Medi BM; Singh J
    Int J Pharm; 2006 Feb; 308(1-2):61-8. PubMed ID: 16356671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
    Bodles-Brakhop AM; Draghia-Akli R
    Expert Rev Vaccines; 2008 Sep; 7(7):1085-101. PubMed ID: 18767956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation delivery of DNA vaccines: prospects for success.
    Sardesai NY; Weiner DB
    Curr Opin Immunol; 2011 Jun; 23(3):421-9. PubMed ID: 21530212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines.
    Zhu Y; Lu F; Dai Y; Wang X; Tang J; Zhao S; Zhang C; Zhang H; Lu S; Wang S
    Vaccine; 2010 Jul; 28(32):5347-55. PubMed ID: 20483191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Needle-free vaccine injection.
    Kendall MA
    Handb Exp Pharmacol; 2010; (197):193-219. PubMed ID: 20217531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months.
    Tsang C; Babiuk S; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel P
    Vaccine; 2007 Jul; 25(30):5485-94. PubMed ID: 17408815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.